Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

Abstract

As our knowledge of type 1 (insulin-dependent) diabetes increases, so does our appreciation for the pathogenic complexity of this disease and the challenges associated with its treatment. Many new concepts about the pathogenesis of this disorder have arisen. The role of genetics versus environment in disease formation has been questioned, and the basis on which type 1 diabetes is characterised and diagnosed is the subject of much debate. Additionally, the care and treatment of patients with type 1 diabetes has seen a rapid evolution; with genetically engineered insulins, glucose monitoring devices, and algorithms all contributing to a decrease in disease-related complications. We focus this seminar on these changing views, and offer a new perspective on our understanding of the pathogenesis of type 1 diabetes and on principles for therapeutic management of patients with this disorder.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(01)05415-0

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 99 references

Research works printed but not linked: 4

  1. Kimpimaki, 2000, Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group, J Clin Endocrinol Metab, 85, 1126
  2. Turner, 1997, UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group, Lancet, 350, 1288, 10.1016/S0140-6736(97)03062-6 · DOI · Paper page
  3. Seissler, 1998, Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease, Diabetologia, 41, 891, 10.1007/s001250051004 · DOI
  4. Verge, 1998, Combined use of autoantibodies (IA-2ab, Gadab, IAA, ICA) in type 1 diabetes: Combinatorial islet autoantibody workshop, Diabetes, 47, 1857, 10.2337/diabetes.47.12.1857 · DOI · Paper page

Cited by

See all 1,491

Metadata

Authors
Atkinson, M. A., & Eisenbarth, G. S.
Affiliations
  • University of Florida Health (US)
  • University of Colorado Health (US)
Corresponding author
Atkinson, Mark A
Venue
The Lancet
Publisher
Elsevier BV
Published
2001-07
Volume
358
Issue
9277
Pages
221-229
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2001295992
Cited by
1,491
References
99
Citations by year
2026: 18 · 2025: 34 · 2024: 41 · 2023: 43 · 2022: 45 · 2021: 50 · 2020: 51 · 2019: 56 · 2018: 60 · 2017: 59 · 2016: 59 · 2015: 53 · 2014: 90 · 2013: 85 · 2012: 83
FWCI
5.33
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
type 1 diabetes, pathogenesis, genetic and environmental factors, diabetes diagnosis, glucose monitoring devices, diabetes treatment, diabetes complications
MeSH terms
Adult, Autoantibodies, Autoimmune Diseases, Child, Diabetes Mellitus, Type 1, Humans, Insulin, Blood Glucose Self-Monitoring, Incidence, Islets of Langerhans Transplantation, Age of Onset, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. https://app.cochat.ai/papers/10.1016/s0140-6736(01)05415-0
The paper
Atkinson, M. A., & Eisenbarth, G. S. (2001). Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet. https://doi.org/10.1016/s0140-6736(01)05415-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.